Feature Channels:

Article ID: 705620

A focus on high-risk tuberculosis patients may be the answer to stalled progress in stamping out the illness in the United States.

Article ID: 705595

Researchers analyzed data from more than 1,000 breast cancer patients and found that breast cancer behaves differently than other cancers that are currently treated with immunotherapy. They identified seven clusters of breast cancer patients based on the immune evasion mechanisms that breast cancer uses to avoid detection.

Article ID: 705463

Summaries of this year’s notable advances at Fred Hutchinson Cancer Research Center and beyond.

Article ID: 705402

Research in mouse cells identifies defective metabolic pathway in aging immune T cells. The pathway is critical for switching T cells from dormancy into illness-fighting mode. In experiments, researchers restored lagging T-cell function by adding small-molecule compounds. Findings suggest possible mechanism behind weakened immunity common in the elderly.

Article ID: 705327

Dr. Matthias von Herrath, M.D., who founded the Type 1 Diabetes Center at La Jolla Institute for Immunology (LJI) has been identified as the world’s top expert in Type 1 Diabetes by Expertscape, an organization that provides tools to quickly and easily find the best clinicians or pioneering scientists specializing in a wide range of medical conditions or biomedical topics.

Article ID: 705292

The new Sherman Institute will advance basic research on novel therapies for a range of disorders, including autoimmune, neurodegenerative, and infectious diseases, as well as cancer.

Article ID: 705285

Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers. A new study, led by former FSU graduate student Noah Webb, along with current graduate student Benjamin Dowd-Arrow and Associate Professors of Sociology Miles Taylor and Amy Burdette, was recently published in Public Health Reports.

Article ID: 705279

SLU pediatric researchers received $412,500 from the NIH to study how fetal exposure to inflammation can alter immune responses after birth.